Table 2.
Changes in physical activity from baseline to endpoint
| Placebo tablets | Vitamin D tablets | P | |||
|---|---|---|---|---|---|
| HP yogurt | NP yogurt | HP yogurt | NP yogurt | ||
| n | 38 | 39 | 38 | 39 | |
| Average CPM (Δ) | − 173 (292) | − 243 (260) | − 72 (348) | − 123 (327) | 0.056 |
| Sedentary (Δ min/day) | 24.7 (69.1) | 46.4 (70.8) | 13.8 (59.6) | 34.1 (53.2) | 0.29 |
| Light (Δ min/day) | − 26.4 (70.3) | − 41.1 (59.3) | − 9.8 (60.0) | − 27.8 (60.4) | 0.43 |
| Moderate (Δ min/day) | − 7.9 (14.3) | − 8.2 (15.0) | − 2.0 (18.8) | − 4.0 (15.7) | 0.094 |
| Vigorous (Δ min/day) | − 3.0 (6.3) | − 2.9 (5.1) | − 0.1 (10.7) | − 1.3 (8.1) | 0.14 |
| MVPA (Δ min/day) | − 10.9 (18.5) | − 11.0 (18.9) | − 2.1 (25.6) | − 5.2 (22.5) | 0.075 |
| Steps (Δ) | − 1445 (3261) | − 2426 (2587) | − 840 (2729) | − 1273 (3302) | 0.18 |
Data are presented as mean (SD) change from baseline to endpoint. P values are from one-way ANCOVA-models testing group differences with study group as fixed factor
CPM counts per minute, HP high protein, NP normal protein, MVPA moderate-vigorous physical activity, Δ change from baseline to endpoint